Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Yana V. Vishnevskaya"'
Autor:
Tatiana S. Belysheva, Yana V. Vishnevskaya, Tatiana V. Nasedkina, Marina A. Emelyanova, Ivan S. Abramov, Kristina V. Orlova, Ludmila N. Lubchenko, Igor A. Utyashev, Marina B. Doroshenko, Lev V. Demidov, Mamed D. Aliev
Publikováno v:
Diagnostic Pathology, Vol 14, Iss 1, Pp 1-9 (2019)
Abstract Background A giant congenital melanocytic nevus (GCMN) is found in 0.1% of live-born infants. If present, the lesion has a chance of about 6% to develop into malignant melanoma. Both children and adults can be affected by malignant melanoma
Externí odkaz:
https://doaj.org/article/ab9b7b4e1f8a40e1853614efbd30c4b6
Autor:
Lev V. Demidov, I. S. Abramov, Yana V Vishnevskaya, T. V. Nasedkina, Mamed D. Aliev, Ludmila N. Lubchenko, Igor A Utyashev, Marina B. Doroshenko, Tatiana S. Belysheva, Kristina V. Orlova, M. A. Emelyanova
Publikováno v:
Diagnostic Pathology, Vol 14, Iss 1, Pp 1-9 (2019)
Diagnostic Pathology
Diagnostic Pathology
Background A giant congenital melanocytic nevus (GCMN) is found in 0.1% of live-born infants. If present, the lesion has a chance of about 6% to develop into malignant melanoma. Both children and adults can be affected by malignant melanoma arising i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa4d3b3d04c6f7f3c39a62f3d7a5f803
http://link.springer.com/article/10.1186/s13000-019-0797-1
http://link.springer.com/article/10.1186/s13000-019-0797-1
Autor:
Iryna V. Zagorulko, Tatyana V. Kalinina, Aleksandr B. Lysenko, Sergei V. Gubarev, Yana V. Vishnevskaya
Publikováno v:
New Technologies, Development and Application IV ISBN: 9783030752743
Complex studies of the structure and strength properties of Al-Cr alloys prepared in the shape of ribbons with a thickness of l = (30–80) μm by rolling a melt jet in steel rolls as well as by reflow the surface of massive samples to a depth of h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26dd440e50319cace28a8816afd3d520
https://doi.org/10.1007/978-3-030-75275-0_22
https://doi.org/10.1007/978-3-030-75275-0_22
Autor:
Kadagidze Zg, Esma Shoua, Yana V Vishnevskaya, Andrey Meshcheryakov, Zabotina Tn, L G Zhukova, Inna P. Ganshina, Irina V. Kolyadina, Slavina Eg, A. I. Chertkova, Olga O. Gordeeva
Publikováno v:
Journal of Clinical Oncology. 38:e12581-e12581
e12581 Background: Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer. Pathologic complete response (pCR) achievement during neoadjuvant chemotherapy (NACT) is very important for these pts as it correlates with long-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b604230ad650550558e9fb8afafa8ee
https://doi.org/10.1200/jco.2020.38.15_suppl.e12581
https://doi.org/10.1200/jco.2020.38.15_suppl.e12581
Autor:
Alla Markovich, V. V Delektorskaya, Nadezhda Fedorovna Orel, Kristina V. Orlova, Lev V. Demidov, T.T. Kondratieva, Somasundaram Subramanian, Yana V Vishnevskaya
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 32:e236-e237
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a9c58670a9efabc3540a521cfdf30e
https://doi.org/10.1111/jdv.14769
https://doi.org/10.1111/jdv.14769
Autor:
G A Frank, Irina V. Kolyadina, Irina V. Poddubnaya, Nikita Savelov, Yana V Vishnevskaya, Olga O. Gordeeva, L G Zhukova, Elena Tuzova, L E Zavalishina, Aleksandr V. Arkhipov, Vahan Yurikovich Bokhian, Dmitry Komov, Yulia Andreeva, Inna P. Ganshina
Publikováno v:
Journal of Clinical Oncology. 37:e12102-e12102
e12102 Background: Effect of neoadjuvant chemotherapy (NACT) is extremely important for patients with HER2-positive breast cancer stage II-III as it correlates with long-term outcomes. However, predictive factors for achieving complete pathologic res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f159560aca869ceb82c4d9ab1473f2d
https://doi.org/10.1200/jco.2019.37.15_suppl.e12102
https://doi.org/10.1200/jco.2019.37.15_suppl.e12102
Autor:
Olga Pavlikova, Irina V. Kolyadina, Vahan Yurikovich Bokhian, Yana V Vishnevskaya, L G Zhukova, Dmitrii Komov, Inna P. Ganshina, Olga O. Gordeeva, Irina V. Poddubnaya
Publikováno v:
Journal of Clinical Oncology. 36:e12656-e12656
e12656Background: The biosimilar of trastuzumab (Herticad ®) used in Russian clinical practice since March 2016, but the effectiveness, safety and economic rationality of biosimilar of trastuzumab ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1626bf05fafc2f1e3260a1998740a243
https://doi.org/10.1200/jco.2018.36.15_suppl.e12656
https://doi.org/10.1200/jco.2018.36.15_suppl.e12656
Autor:
L G Zhukova, E I Borisova, D. Khochenkov, Inna P. Ganshina, E. Lubennikova, Mikhail Lichinitser, Yana V Vishnevskaya, E V Stepanova
Publikováno v:
Journal of Clinical Oncology. 36:e12562-e12562
e12562Background: A few prognostic factors are used to make decision on breast cancer (BC) treatment. Researches to identify novel prognostic and predictive factors are still actual. Two DNA repair...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::466f0bb9b17c75626b8cf04f488457f0
https://doi.org/10.1200/jco.2018.36.15_suppl.e12562
https://doi.org/10.1200/jco.2018.36.15_suppl.e12562
Autor:
Irina V. Tsyganova, Ekaterina A. Lesovaya, V. V Delektorskaya, Lev V. Demidov, Kirill I. Kirsanov, Valery V. Nazarova, Kristina V. Orlova, Marianna G. Yakubovskaya, Yana V Vishnevskaya
Publikováno v:
Journal of Clinical Oncology. 36:e21605-e21605
e21605Background: Merkel cell carcinoma (MCC) is a rare, but highly aggressive skin cancer with the clonal integration of Merkel cell polyomavirus (MCPyV). The aim of this study was to assess the p...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4923f0ee3e92b7d2ed047b789d498949
https://doi.org/10.1200/jco.2018.36.15_suppl.e21605
https://doi.org/10.1200/jco.2018.36.15_suppl.e21605
Autor:
Irina V. Poddubnaya, Yana V Vishnevskaya, Georgii Frank, Olga Pavlikova, Irina V. Kolyadina, Yulia Andreeva, Dmitrii Komov
Publikováno v:
Journal of Clinical Oncology. 35:e12121-e12121
e12121 Background: Residual tumor is an important prognostic factor after neoadjuvant therapy, however, p53 expression in the residual breast tumors poorly understood. Methods: In our study included 164 Russian women (24-76, median age - 47) with bre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec05ef212d168ff45fcc9344287e23d1
https://doi.org/10.1200/jco.2017.35.15_suppl.e12121
https://doi.org/10.1200/jco.2017.35.15_suppl.e12121